Current and historical daily PE Ratio for Philogen Spa (
STU:78Q
) from 2021 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Philogen Spa stock (STU:78Q) PE ratio as of Apr 24 2024 is 0.
More Details
Philogen Spa (STU:78Q) PE Ratio (TTM) Chart
Philogen Spa (STU:78Q) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 597
- 1
- 2
- 3
- 4
- 5
- 6
- 7
| Philogen Spa PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-16 | At Loss |
| 2024-04-22 | At Loss | 2024-02-15 | At Loss |
| 2024-04-19 | At Loss | 2024-02-14 | At Loss |
| 2024-04-18 | At Loss | 2024-02-13 | At Loss |
| 2024-04-17 | At Loss | 2024-02-12 | At Loss |
| 2024-04-16 | At Loss | 2024-02-09 | At Loss |
| 2024-04-15 | At Loss | 2024-02-08 | At Loss |
| 2024-04-12 | At Loss | 2024-02-07 | At Loss |
| 2024-04-11 | At Loss | 2024-02-06 | At Loss |
| 2024-04-10 | At Loss | 2024-02-05 | At Loss |
| 2024-04-09 | At Loss | 2024-02-02 | At Loss |
| 2024-04-08 | At Loss | 2024-02-01 | At Loss |
| 2024-04-05 | At Loss | 2024-01-31 | At Loss |
| 2024-04-04 | At Loss | 2024-01-30 | At Loss |
| 2024-04-03 | At Loss | 2024-01-29 | At Loss |
| 2024-04-02 | At Loss | 2024-01-26 | At Loss |
| 2024-03-28 | At Loss | 2024-01-25 | At Loss |
| 2024-03-27 | At Loss | 2024-01-24 | At Loss |
| 2024-03-26 | At Loss | 2024-01-23 | At Loss |
| 2024-03-25 | At Loss | 2024-01-22 | At Loss |
| 2024-03-22 | At Loss | 2024-01-19 | At Loss |
| 2024-03-21 | At Loss | 2024-01-18 | At Loss |
| 2024-03-20 | At Loss | 2024-01-17 | At Loss |
| 2024-03-19 | At Loss | 2024-01-16 | At Loss |
| 2024-03-18 | At Loss | 2024-01-12 | At Loss |
| 2024-03-15 | At Loss | 2024-01-11 | At Loss |
| 2024-03-14 | At Loss | 2024-01-10 | At Loss |
| 2024-03-13 | At Loss | 2024-01-09 | At Loss |
| 2024-03-12 | At Loss | 2024-01-08 | At Loss |
| 2024-03-11 | At Loss | 2024-01-05 | At Loss |
| 2024-03-08 | At Loss | 2024-01-04 | At Loss |
| 2024-03-07 | At Loss | 2024-01-03 | At Loss |
| 2024-03-06 | At Loss | 2024-01-02 | At Loss |
| 2024-03-05 | At Loss | 2023-12-29 | At Loss |
| 2024-03-04 | At Loss | 2023-12-28 | At Loss |
| 2024-03-01 | At Loss | 2023-12-27 | NaN |
| 2024-02-29 | At Loss | 2023-12-22 | NaN |
| 2024-02-28 | At Loss | 2023-12-21 | NaN |
| 2024-02-27 | At Loss | 2023-12-20 | NaN |
| 2024-02-26 | At Loss | 2023-12-19 | NaN |
| 2024-02-23 | At Loss | 2023-12-18 | NaN |
| 2024-02-22 | At Loss | 2023-12-15 | NaN |
| 2024-02-21 | At Loss | 2023-12-14 | NaN |
| 2024-02-20 | At Loss | 2023-12-13 | NaN |
Philogen Spa (STU:78Q) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Philogen Spa
NAICS : 325412
ISIN : IT0005373789
Compare
Compare
Traded in other countries / regions
PHIL.Italy78Q.GermanyPHILm.UK IPO Date
2021-03-08Description
Philogen Spa is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, it derives a majority of revenue from the USA.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers